Japan s Mitsui & Co
said on Thursday it had teamed up with Rohto
Pharmaceutical Co to buy Eu Yan Sang International in a
deal valuing the Singapore-based traditional Chinese medicines
firm at S$800.
Mitsui, Rohto Pharmaceutical take 86% stake in Eu Yan Sang for S$687 million businesstimes.com.sg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstimes.com.sg Daily Mail and Mail on Sunday newspapers.
Japanese firms Mitsui and Rohto have agreed to jointly buy Eu Yan Sang International (EYS), a Singapore company that retails traditional Chinese medicines.